Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cardiovascular Research|February 16, 2023
Innate immune memory in cardiometabolic diseaseHarsh Bahrar, Siroon Bekkering, Rinke Stienstra, et al.Atherosclerosis Plus|January 1, 2026
Innate immune cell function in statin-treated patients with severe hypercholesterolemia is comparable to normocholesterolemic individuals: A cross-sectional studyHarsh Bahrar, Kim Steward, Liesbeth van Emst, et al.Molecular Cancer|October 26, 2014
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapyMari Iida, Toni M Brand, Megan M Starr, et al.Clinical Pharmacology and Therapeutics|August 8, 2024
The Effect of Low-Dose Colchicine on the Phenotype and Function of Neutrophils and Monocytes in Patients with Chronic Coronary Artery Disease: A Double-Blind Randomized Placebo-Controlled Cross-Over StudyHelin Tercan, Amber van Broekhoven, Harsh Bahrar, et al.Journal of the American Heart Association|March 20, 2026
Effect of 2 Weeks of Time-Restricted Eating on Innate Immunity and Systemic Inflammation in Patients With a History of Myocardial Infarction: A Randomized-Controlled Crossover StudyJonathan Los, Wieteke Broeders, Harsh Bahrar, et al.Molecular Cancer Therapeutics|July 17, 2016
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to CetuximabMari Iida, Harsh Bahrar, Toni M Brand, et al.Iscience|November 4, 2024
Single high-fat challenge and trained innate immunity: A randomized controlled cross-over trialJulia van Tuijl, Julia I P van Heck, Harsh Bahrar, et al.International Journal of Obesity (2005)|December 22, 2023
Sex-specific association of visceral and subcutaneous adipose tissue volumes with systemic inflammation and innate immune cells in people living with obesityInge C L van den Munckhof, Harsh Bahrar, Kiki Schraa, et al.Immunology|April 23, 2025
Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway InhibitionTsz Kin Suen, Burcu Al, Thomas Ulas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2015
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M Brand, Mari Iida, Andrew P Stein, et al.Pageof 2